Fertility and Sterility
Volume 93, Issue 1 , Pages 220-228 , 1 January 2010

Role of estrogen receptors in menstrual cycle–related neoangiogenesis and their influence on endothelial progenitor cell physiology

  • Carlo Foresta, M.D.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • Corresponding Author InformationReprint requests: Carlo Foresta, M.D., Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Via Gabelli 63, 35121 Padova, Italy (FAX: 39-49-8218520).
    • ,
  • Luca De Toni, B.S.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • ,
  • Antonella Di Mambro, M.D.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • ,
  • Alberto Ferlin, M.D.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • ,
  • Lisa Perilli, B.S.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • ,
  • Ilaria Bertuzzi, B.S.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy
    • ,
  • Alessandro Galan, M.D.

      Affiliations

    • Department of Ophthalmology, S. Antonio Hospital, Padova, Italy
    • ,
  • Daniela Zuccarello, M.D.

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, Center for Male Gamete Cryopreservation, University of Padova, Padova, Italy

Received 3 September 2008 ,Revised 18 September 2008 ,Accepted 19 September 2008.

References 

  1. Arnal JF, Scarabin PY, Trémollières F, Laurell H, Gourdy P. Estrogens in vascular biology and disease: where do we stand today?. Curr Op Lipidol. 2007;18:554–560
  2. Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006;114:2261–2270
  3. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J. 1992;26:886–892
  4. Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001;21:6–12
  5. Kyriakides ZS, Petinakis P, Kaklamanis L, Sbarouni E, Karayannakos P, Iliopoulos D, et al. Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. Cardiovasc Res. 2001;49:626–633
  6. Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation. 2006;113:1605–1614
  7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  8. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362–367
  9. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–637
  10. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864
  11. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996;94:727–733
  12. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 1997;3:545–548
  13. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, et al. Cloning of the human oestrogen receptor cDNA. J Ster Biochem Mol Biol. 1986;24:77–83
  14. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925–5930
  15. Walker VR, Korach KS. Estrogen receptor knockout mice as a model for endocrine research. ILAR J. 2004;45:455–461
  16. Foresta C, Zuccarello D, Biagioli A, De Toni L, Prana E, Nicoletti V, et al. Oestrogen stimulates endothelial progenitor cells via oestrogen receptor-alpha. Clin Endocrinol. 2007;67:520–525
  17. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002;295:505–508
  18. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol. 2005;38:289–297
  19. Lima e Silva R, Shen J, Hackett SF, Kachi S, Akiyama H, Kiuchi K, et al. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 2007;21:3219–3230
  20. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463–471
  21. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 2000;95:3289–3296
  22. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322–1328
  23. Majka M, Ratajczak J, Kowalska MA, Ratajczak MZ. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur J Haematol. 2000;64:164–172
  24. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A, et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metabol. 2006;91:4599–4602
  25. Masuda H, Kalka C, Takahashi T, Yoshida M, Wada M, Kobori M, et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res. 2007;101:598–606
  26. Bowman SP, Leake A, Morris ID. Biological activity and steroid receptor interactions of cyclofenil with the oestrogen target tissues of the brain, pituitary gland and uterus of the rat. J Reprod Fertil. 1982;65:355–366
  27. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol. 2003;206:13–22
  28. Zhao X, Huang L, Yin Y, Fang Y, Zhao J, Chen J. Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways. Microvasc Res. 2008;75:45–52
  29. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Throm Vasc Biol. 2008;28:997–1004
  30. Parmo-Cabañas M, Molina-Ortiz I, Matías-Román S, García-Bernal D, Carvajal-Vergara X, Valle I, et al. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes. Am J Pathol. 2006;208:108–118
  31. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–1924
  32. Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. Int J Biochem Cell Biol. 2006;99:690–705
  33. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001;276:43503–43508
  34. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006;12:557–567
  35. Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J. 2006;20:2559–2561
  36. Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, et al. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod. 2006;12:367–375
  37. Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, Sobel M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg. 2004;39:655–660
  38. Makinoda S, Mikuni M, Sogame M, Kobamatsu Y, Furuta I, Yamada H, et al. Erythropoietin, granulocyte-colony stimulating factor, interleukin-1 beta and interleukin-6 during the normal menstrual cycle. Int J Gynaecol Obstet. 1996;55:265–271

 C.F. has nothing to disclose. L.D. has nothing to disclose. A.D. has nothing to disclose. A.F. has nothing to disclose. L.P. has nothing to disclose. I.B. has nothing to disclose. A.G. has nothing to disclose. D.Z. has nothing to disclose.

PII: S0015-0282(08)04062-4

doi: 10.1016/j.fertnstert.2008.09.059

Fertility and Sterility
Volume 93, Issue 1 , Pages 220-228 , 1 January 2010

Article Tools

* Image Usage & Resolution